Considerations for use of ketamine to treat depression in Australia and New Zealand.
Saved in:
| Title: | Considerations for use of ketamine to treat depression in Australia and New Zealand. |
|---|---|
| Authors: | Bayes, Adam, Dong, Vanessa, Loo, Colleen |
| Source: | Australian & New Zealand Journal of Psychiatry. Nov2019, Vol. 53 Issue 11, p1117-1120. 4p. |
| Subjects: | Ketamine, Mental depression, Drug prescribing, Medical prescriptions, Physician practice patterns, Inappropriate prescribing (Medicine) |
| Geographic Terms: | Australia, New Zealand |
| Abstract: | The article discusses about the considerations for use of ketamine to treat depression in Australia and New Zealand. Topics discussed include different mechanism of action compared to standard antidepressant (AD) medications and N-methyl-Daspartate (NMDA) receptor antagonist; depression refractory to treatment with electroconvulsive therapy (ECT); and a table is also present related to State, territory and country-based regulations relevant to prescribing ketamine for depression. |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 139456346 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Considerations for use of ketamine to treat depression in Australia and New Zealand. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Bayes%2C+Adam%22">Bayes, Adam</searchLink><br /><searchLink fieldCode="AR" term="%22Dong%2C+Vanessa%22">Dong, Vanessa</searchLink><br /><searchLink fieldCode="AR" term="%22Loo%2C+Colleen%22">Loo, Colleen</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Australian+%26+New+Zealand+Journal+of+Psychiatry%22">Australian & New Zealand Journal of Psychiatry</searchLink>. Nov2019, Vol. 53 Issue 11, p1117-1120. 4p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Ketamine%22">Ketamine</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+depression%22">Mental depression</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+prescribing%22">Drug prescribing</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+prescriptions%22">Medical prescriptions</searchLink><br /><searchLink fieldCode="DE" term="%22Physician+practice+patterns%22">Physician practice patterns</searchLink><br /><searchLink fieldCode="DE" term="%22Inappropriate+prescribing+%28Medicine%29%22">Inappropriate prescribing (Medicine)</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Australia%22">Australia</searchLink><br /><searchLink fieldCode="DE" term="%22New+Zealand%22">New Zealand</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: The article discusses about the considerations for use of ketamine to treat depression in Australia and New Zealand. Topics discussed include different mechanism of action compared to standard antidepressant (AD) medications and N-methyl-Daspartate (NMDA) receptor antagonist; depression refractory to treatment with electroconvulsive therapy (ECT); and a table is also present related to State, territory and country-based regulations relevant to prescribing ketamine for depression. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=139456346 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/0004867419866510 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 4 StartPage: 1117 Subjects: – SubjectFull: Ketamine Type: general – SubjectFull: Mental depression Type: general – SubjectFull: Drug prescribing Type: general – SubjectFull: Medical prescriptions Type: general – SubjectFull: Physician practice patterns Type: general – SubjectFull: Inappropriate prescribing (Medicine) Type: general – SubjectFull: Australia Type: general – SubjectFull: New Zealand Type: general Titles: – TitleFull: Considerations for use of ketamine to treat depression in Australia and New Zealand. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bayes, Adam – PersonEntity: Name: NameFull: Dong, Vanessa – PersonEntity: Name: NameFull: Loo, Colleen IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 00048674 Numbering: – Type: volume Value: 53 – Type: issue Value: 11 Titles: – TitleFull: Australian & New Zealand Journal of Psychiatry Type: main |
| ResultId | 1 |